SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra ...
Patient with aspiration pneumonia on a ventilator and intubated with a nasogastric tube in an intensive care unit (ICU). Actemra (tocilizumab) is an interleukin-6 receptor antagonist. The Food and ...
Based partly on results of clinical trials for patients from underrepresented racial and ethnic groups, the Food and Drug Administration (FDA) yesterday approved the use of Actemra for hospitalized ...
Roche RHHBY announced that the FDA has approved Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients who are receiving systemic corticosteroids and ...
Please enable JavaScript to read this content. Tocilizumab an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis. [Photo: Courtesy] The long ...
ZURICH, Nov 19 (Reuters) - Roche's (ROG.S), opens new tab Actemra helped the sickest COVID-19 patients in a 303-patient study, the trial's lead investigator said on Thursday, bolstering what has been ...
Roche RHHBY recently announced that the European Medicines Agency’s (“EMA”) Committee for Medicinal Products for Human Use (“CHMP”) has recommended extending the marketing authorization for rheumatoid ...
(RTTNews) - The U.S. Food and Drug Administration has approved Roche's (RHHBY) Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients who are receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback